A Randomized, Placebo Controlled, Parallel Group, Multicenter Study to Evaualte the Efficacy and Safety of Ulipristal Acetate in Women With Anemia Associated With Uterine Leiomyomas.
Latest Information Update: 14 Feb 2013
Price :
$35 *
At a glance
- Drugs Ulipristal (Primary)
- Indications Uterine leiomyoma
- Focus Registrational; Therapeutic Use
- 06 Feb 2013 Status changed from active, no longer recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 14 Aug 2012 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.
- 08 Aug 2012 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.